Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
September 19th, 2022
2.7K views
This protocol describes the synthesis of cyclic cell-penetrating peptides with aromatic cross-links and the evaluation of their permeability across biological barriers.
Overview
This protocol outlines the synthesis of cyclic cell-penetrating peptides designed to enhance permeability across biological barriers. The incorporation of aromatic cross-links improves peptide hydrophobicity, facilitating better drug delivery to tumor cells.
Key Study Components
Area of Science
- Biochemistry
- Pharmaceutical Sciences
- Drug Delivery Systems
Background
- Cancer treatment is hindered by physiological barriers limiting drug access to tumor cells.
- Novel molecular transporters are needed to improve therapeutic efficacy.
- Cyclic cell-penetrating peptides can enhance cell-to-cell penetration.
- Aromatic cross-links can improve peptide properties compared to traditional methods.
Purpose of Study
- Synthesize cyclic cell-penetrating peptides for improved permeability.
- Evaluate the effectiveness of aromatic cross-links in enhancing peptide properties.
- Develop a method that does not require metal catalysts for cyclization.
Methods Used
- Manual peptide synthesis apparatus setup in a fume hood.
- Substitution reactions with cysteines and resin for cyclization.
- Evaluation of peptide hydrophobicity and permeability.
- Comparison with hydrophilic lactam or triazole cross-links.
Main Results
- Aromatic cross-links significantly enhance peptide hydrophobicity.
- Cyclic peptides show improved permeability across biological barriers.
- The method allows for easy cyclization without metal catalysts.
- Potential for increased drug delivery efficiency to tumor cells.
Conclusions
- Cyclic cell-penetrating peptides with aromatic cross-links are promising for drug delivery.
- The synthesis method is efficient and avoids the use of metal catalysts.
- Further studies are needed to assess clinical applications in cancer treatment.
Frequently Asked Questions
What are cyclic cell-penetrating peptides?
Cyclic cell-penetrating peptides are designed to enhance the delivery of therapeutics across biological barriers.
How do aromatic cross-links improve peptide properties?
Aromatic cross-links increase the hydrophobicity of peptides, enhancing their permeability.
What is the significance of avoiding metal catalysts in synthesis?
Avoiding metal catalysts simplifies the synthesis process and reduces potential side effects in therapeutic applications.
What challenges do cancer therapies face?
Cancer therapies often struggle with limited access to deeper tumor cells due to physiological barriers.
What methods are used to evaluate peptide permeability?
Peptide permeability is evaluated through comparative studies of hydrophobicity and biological barrier penetration.
What future studies are suggested?
Further studies should explore the clinical applications of these peptides in enhancing drug delivery for cancer treatment.
Executive Industry Relevance
Overcoming biological barriers to drug delivery remains a critical challenge in oncology R&D, directly impacting therapeutic access to tumor cells and recurrence risk. The construction of cyclic cell-penetrating peptides (CPPs) with enhanced proteolytic stability and permeability addresses a key inflection point in the delivery pipeline. This capability supports portfolio strategies focused on improving intracellular delivery and reducing attrition due to poor tissue penetration.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of cellular uptake mechanisms for novel delivery vectors.
- Supports biological de-risking by comparing cyclic and linear CPP stability and permeability.
- Facilitates predictive confidence in transporter selection for downstream drug conjugates.
Screening & Assay Development
- Provides validated peptide constructs for quantitative permeability assays.
- Enables reproducible assessment of proteolytic stability in serum-containing environments.
- Supports standardization of cell-based barrier penetration models for compound evaluation.
Translational & Preclinical Research
- Aligns with disease-relevant models by simulating tumor microenvironment barriers.
- Enables continuity from in vitro permeability to preclinical tissue penetration studies.
- De-risks advancement of delivery platforms by demonstrating enhanced barrier crossing.
Pipeline & Workflow Integration
This method integrates at the interface of delivery vector optimization and preclinical model validation, bridging early discovery and translational research.
- Discovery Biology: Supports hypothesis testing on peptide structure-function relationships for barrier penetration.
- Screening: Delivers quantitative readouts of intracellular fluorescence and proteolytic stability.
- Analytics: Utilizes HPLC, LC-MS, and flow cytometry for comparative analysis of peptide constructs.
- Translational Research: Connects in vitro barrier models to in vivo delivery potential in oncology settings.
- Enterprise Reuse: Establishes a modular platform for evaluating diverse CPP sequences and modifications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in delivery vector selection and mechanistic de-risking.
- Operational Value: Standardizes synthesis and evaluation workflows for CPPs with improved reproducibility.
- Strategic Value: Enables better go/no-go decisions for delivery technologies targeting solid tumors.
- Portfolio Impact: Supports risk-adjusted prioritization of drug delivery platforms with enhanced tissue penetration.
Implementation Considerations
- Requires expertise in peptide synthesis and analytical characterization (HPLC, LC-MS).
- Demands access to cell culture, fluorescence microscopy, and flow cytometry infrastructure.
- Necessitates cross-team standardization of permeability and stability assays.
- Adaptation may be needed for different peptide sequences or biological models due to steric effects.
- Efficiency of cyclization and barrier penetration may vary with peptide length and sequence.
Biopharma FAQs
Why does null hypothesis testing matter for CPP permeability assays?
Null hypothesis testing enables objective comparison between cyclic and linear CPPs, ensuring that observed differences in permeability and stability are statistically significant and not due to random variation.
How does independent variable isolation fit peptide cyclization studies?
Isolating variables such as peptide structure and cross-link type allows teams to attribute changes in barrier penetration and proteolytic stability directly to cyclization, supporting mechanistic de-risking in delivery vector optimization.
What do quantitative fluorescence measurements enable in CPP evaluation?
Quantitative fluorescence readouts provide reproducible metrics for intracellular uptake and trans-barrier penetration, facilitating data-driven selection of CPP candidates for further development.
Why are replication requirements critical for cross-functional CPP workflows?
Replication ensures that permeability and stability findings are robust across different experimental runs and teams, supporting reliable advancement decisions and cross-site standardization.
What statistical analysis capabilities are required before CPP platform implementation?
Teams must apply statistical methods to compare permeability and stability data, validate assay reproducibility, and confirm that enhancements in cyclic CPPs are significant before integrating them into broader drug delivery pipelines.
Chapters in this video
0:04
Introduction
1:10
Equipment Preparation
1:44
Synthesis of FITC‐Labeled Linear R8 Peptide and FITC‐Labeled Stapled R8 Peptide
5:49
Exploration of the Cell‐to‐Cell Penetration of the Peptides Using Transwell Models
7:06
Results: Synthesis of FITC‐R8 and FITC‐sR8‐4 Using Solid‐Phase Peptide Synthesis and Evaluation of Their Trans‐Barrier Permeability
9:06
Conclusion
